Friday, January 25, 2013

• Dover Weakness Seen as Overdone and 4 Stock Analyses Attracting Attentionat Wall St. Cheat Sheet (Fri, Jan 25)

Tuesday, January 22, 2013

• Analyst Favorites With Strong Buyback Activity: ViroPharma Ranks As a Top Pickat Forbes (Tue, Jan 22)

Friday, January 18, 2013

• Data on ViroPharma's CinryzeZacks (Fri, Jan 18)

Thursday, January 17, 2013

• Donor Feces Cure Recurrent Diarrheal Infection, Study Showsat Bloomberg (Thu, Jan 17)

Monday, January 14, 2013

• The Upward Climb Of Halozyme Therapeuticsat Seeking Alpha (Mon, Jan 14)

Thursday, January 10, 2013

• Urban Outfitters Reiterated at Hold and 3 Must-See Reiterated Ratingsat Wall St. Cheat Sheet (Thu, Jan 10)
• ViroPharma's FDA lawsuit dismissedat bizjournals.com (Thu, Jan 10)

Wednesday, January 9, 2013

• 4 Healthcare Stocks for Investors to Check Outat Wall St. Cheat Sheet (Wed, Jan 9)
• ViroPharma Suit Against FDA Over Generic Vancocin Tossedat Bloomberg (Wed, Jan 9)
• VIROPHARMA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Wed, Jan 9)

Tuesday, January 8, 2013

• Upbeat 2013 from ViroPharmaZacks (Tue, Jan 8)

Monday, January 7, 2013

• ViroPharma forecasts 2013 revenue, Cinryze salesAP (Mon, Jan 7)
• ViroPharma announces sales guidance for 2013, shares riseat bizjournals.com (Mon, Jan 7)
• VIROPHARMA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 7)

Friday, January 4, 2013

• VIROPHARMA INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Fri, Jan 4)
• The Story Behind Little Halozyme’s Seemingly Exciting Hookup With PfizerYCharts (Fri, Jan 4)

Sunday, December 30, 2012

• Will ViroPharma Disappoint Analysts Next Quarter?at Motley Fool (Sun, Dec 30)

Saturday, December 29, 2012

• Pfizer’s Backing Spurs Halozyme's Growthat Motley Fool (Sat, Dec 29)

Monday, December 24, 2012

• MDCO Scores in SOLO-1 TrialZacks (Mon, Dec 24)
• 1 Reason ViroPharma May Be Headed for a Slowdownat Motley Fool (Mon, Dec 24)

Friday, December 21, 2012

• Halozyme Jumps Most in Six Years on Pfizer Partnershipat Bloomberg (Fri, Dec 21)
• Halozyme Therapeutics Set To Shine On Deal With Pfizerat Seeking Alpha (Fri, Dec 21)
• Halozyme Surges on Pfizer Dealat Motley Fool (Fri, Dec 21)

Wednesday, December 19, 2012

• ViroPharma, Halozyme announce initiation of Phase 2b dose to evaluate Cinryzeat theflyonthewall.com (Wed, Dec 19)

Wednesday, December 12, 2012

• VIROPHARMA INC Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online (Wed, Dec 12)

Add VPHM News to My Yahoo!